Enhanced Transdermal Delivery of Granisetron by using Iontophoresis

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 2, 2012, Pages 503-512

  Panzade, Prabhakar ^a   Heda, Ashish ^a   Puranik, Prashant ^a   Patni, Mayur ^a   Mogal, Vipul ^a  

^a GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

Granisetron; Iontophoresis; Penetration enhancer; Poloxamer; Transdermal

Indexed keywords

GRANISETRON; PENETRATION ENHANCING AGENT; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EXPERIMENTAL GUINEA PIG; GEL; IONTOPHORESIS; NONHUMAN;

EID: 84862726539     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ayyappa C, Dipty PJ, Carter A, Russ Morris, Walter LS and Ajay KB. Dermal, Subdermal and Systemic Concentrations of Granisetron by iontophoretic delivery. Pharm. Res. (2005) 22: 1313-1319.
2. Clarke SE, Austin NE, Bloomer JC, Haddock RE, Higham FC, Hollis FJ, Nash M, Shardlow PC, Tasker TC and Woods FR. Metabolism and deposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica (1994) 24: 1119-1131.
3. Sage BH. Iontophoresis. In: Boylan JC. (ed.) Encyclopedia of Pharmaceutical Technology. Vol. 8. Marcel Dekker, New York (1993) 217-247.
4. Singh P, Liu P and Dinh SM. Facilitated transdermal delivery by iontophoresis. In: Bronaugh RL and Maibach HI. Percutaneous Absorption, Drugs-Mechanisms-Methodology. Marcel Dekker, New York (1999) 633-657.
5. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A and Marro D. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Rel. (2000) 64: 129-132.
6. Conjeevaram R, Banga AK and Zhang L. Electrically modulated transdermal delivery of fentanyl. Pharm. Res. (2002) 19: 440-444.
7. Chiang CH, Shao CH and Chen JL. Effects of pH electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide. Drug Dev. Ind. Pharm. (1998) 24: 431-438.
8. Van der Geest R, Banhof M and Bodde HE. Iontophoretic delivery of apomorphine I. In-vitro optimization and validation. Pharm. Res. (1997) 14: 1798-1803.
9. Yashida NH and Roberts MS. Solute molecular size and transdermal iontophoresis across excised human skin. J. Control. Rel. (1993) 25: 177-195.
10. Khademi Kalantari K, Zeinalzade A, Kobarfard F and Nazary moghadam S. The effect and persistency of 1% aluminum chloride hexahydrate iontophoresis in the treatment of primary palmar hyperhidrosis. Iranian J. Pharm. Res. (2011) 9: 641-645.
11. Terzo SD, Behl CR and Nash RA. Iontophoretic transport of a homologous series of ionized and uninonized model compounds: influences of hydrophobicity and mechanistic interpretation. Pharm. Res. (1997) 14: 85-90.
12. Tomohira Y, Machida Y, Onishi H and Nagai T. Iontophoretic transdermalabsorption of insulin and calcitonin in rats with newly-devised switchingtechnique and addition of urea. Int.J. Pharm. (1997) 155:231-239.
13. Zhang I, Schung KK and Edwards DA. Hydrogels with enhanced masstransfer for transdermal drug delivery. J. Pharm. Sci. (1996) 85: 1312-1316.
14. Rowe RC, Sheskey PJ and Weller PJ. Poloxamer. In: Rowe RC, SheskeyPJ, Owen SC, eds. Handbook of Pharmaceutical Excipients. London, UK: Pharmaceutical Press (2003) 447-448.
15. Bentley MVL, Marchetti JM, Ricardo N, Ali-Abi Z and Collett JH. Influence of lecithin on some physical chemical properties of poloxamergels: rheological, microscopic and in-vitro permeation studies. Int. J. Pharm.(1999) 193:49-55.
16. Phipps JB, Scott ER, Gyory JR and Padmanabhan RV. Iontophoresis. In:Swarbrik J, Boylan P, eds. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker (2002) 1578-1588.
17. Banga AK. Electrically Assisted Transdermal and Topical Drug Delivery. London, UK: Taylor and Francis; (1998) 21-24.
18. Vikram K, Kiran B and Rahul T. Enhancement of Iontophoretic Transport of Diphenhydramine Hydrochloride Thermosensitive Gel by Optimization of pH, Polymer Concentration, Electrode Design and Pulse rate. Pharm.Sci.Tech.(2007) 8:E1-E6.
19. Banga AK, Hirsch AC and Upasani RS. Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine.J. Control. Rel. (2005) 103: 113-121.
20. Brand RM and Guy R. Iontophoresis of nicotine in-vitro: pulsatile drug delivery across the skin. J. Control. Rel.(1995) 33: 285-292.
21. Tiwari SB and N. Udupa. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm. (2003) 260: 93-103.
22. Sandip B. Tiwari and N. Udupa. In-vitro iontophoretic transport of ketorolac: synthetic membrane as a barrier. Drug Delivery (2003) 10:161-168.